Exploring how cholesterol production affects the progression of polycystic kidney disease
Official title: Investigating intracellular cholesterol biosynthesis as a regulator of polycystic kidney disease progression
Funded at Ut Southwestern Medical Center · NIH-11048929 · Data updated 2026-11-12
This study is looking at how cholesterol production affects the growth of cysts in people with Autosomal Dominant Polycystic Kidney Disease (ADPKD), and it aims to find new ways to slow down the disease by exploring the role of certain proteins in mice.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | January 1, 2025 |
| Project end | November 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $504,621 |
| NIH project number | 1R01DK139033-01A1 |
| Project ID | NIH-11048929 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
✕Less likely to help
Patients with other forms of kidney disease or those without a diagnosis of ADPKD may not benefit from this research.
What this research studies
This research investigates the role of cholesterol biosynthesis in the progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Researchers are examining how certain proteins, known as sterol regulatory element binding proteins (SREBPs), influence cyst growth in kidney disease. By manipulating these proteins in mouse models, the study aims to identify new therapeutic strategies that could slow down the disease's progression. The findings could lead to innovative treatments that minimize the risks associated with current therapies.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively slow the progression of polycystic kidney disease with fewer side effects.
How similar studies have gone: Previous studies have shown promising results in manipulating cholesterol pathways in kidney disease models, suggesting potential for success in this approach.
Where this research is happening
-
Ut Southwestern Medical Center
Dallas, United States Active
Researchers
- Principal investigator: Lakhia, Ronak — Ut Southwestern Medical Center
- Study coordinator: Lakhia, Ronak
Related research
Other NIH-funded projects on the same topics.
-
Personalized CKD-MBD care using systems biology and AI
A patient-facing program aims to tailor mineral-balance therapy for people with chronic kidney disease by using a computer model and smart decision rules to predict who will respond best to treatments.
-
Mitigating DKA in people with type 1 diabetes and kidney disease using SGLT1/2 inhibitors
This project tests a new way to prevent dangerous diabetic ketoacidosis in people with type 1 diabetes and chronic kidney disease who are using SGLT inhibitors, by tracking ketones in real time and combining glucose-keton data for safer therapy.
-
Chronic Kidney Disease in Children: following young people as they grow up with CKD
A long-term study in kids with chronic kidney disease tracks kidney function and heart health as they transition into adulthood.
-
Chronic Kidney Disease in Children follow-up study
A long-term study that follows kids with kidney disease as they grow into young adults, collecting health data from home and official records.
-
KDARC: Building a research backbone to study aging and kidney disease
Aimed at creating a dedicated infrastructure to advance aging-related kidney disease research so clinicians can better care for older adults.
-
Malaria-related kidney injury and its link to chronic kidney disease in children
This grant looks at why some children who have malaria develop kidney injury and later chronic kidney disease, focusing on how severe malaria affects the kidneys over time.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.